Literature DB >> 11520326

Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects.

G Krämer1.   

Abstract

The majority of epileptic seizures and epilepsies are no longer manifested in childhood and adolescence; instead their incidence is higher at the age of 65 years or older than during the first two decades of life. After cerebrovascular disorders and dementias, epileptic seizures and epilepsies now constitute the third most frequent neurologic problem encountered in the elderly. Important clinical features of epilepsy in the elderly related to the diagnosis include the most common seizure types and causes. Special features of drug treatment for epilepsy in the elderly result not only from the physiologic changes in the elderly but also from the particular pharmacology of the respective drugs. Because elderly patients very often require other long-term medication in addition to antiepileptic therapy, drug interactions between different antiepileptic drugs and between antiepileptics and other drugs can be of major significance. Other special features of pharmacotherapy for epilepsy in the elderly include the presence of liver and kidney diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520326     DOI: 10.1046/j.1528-1157.2001.042suppl.3055.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Animal Models of Posttraumatic Seizures and Epilepsy.

Authors:  Alexander V Glushakov; Olena Y Glushakova; Sylvain Doré; Paul R Carney; Ronald L Hayes
Journal:  Methods Mol Biol       Date:  2016

Review 2.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

Review 3.  Post-stroke seizure and post-stroke epilepsy.

Authors:  P K Myint; E F A Staufenberg; K Sabanathan
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

4.  Selection of antiepileptic drugs in older people.

Authors:  Batool F Kirmani; Diana Mungall Robinson; Adeline Kikam; Ekokobe Fonkem; Daniel Cruz
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.972

Review 5.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 6.  Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development.

Authors:  Abdul Wahab
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

7.  Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives.

Authors:  Nadeem Siddiqui; M Shamsher Alam; James P Stables
Journal:  Eur J Med Chem       Date:  2011-03-10       Impact factor: 6.514

8.  Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience.

Authors:  Luís M Magalhães; Raquel Costa; Mariana Vieira; Joana Moreira; Helena Gama; Patrício Soares-da-Silva
Journal:  Drug Saf       Date:  2021-09-18       Impact factor: 5.606

Review 9.  The causes of new-onset epilepsy and seizures in the elderly.

Authors:  Shasha Liu; Weihua Yu; Yang Lü
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-17       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.